|Last Price$46.71||Day Change (%)-1.31%|
|Open Price$47.60||Day Change ($)-0.62|
|Day Range46.49–48.30||52-Week Range37.02–48.79|
As of Thu 05/23/2013 03:15 AM EDT | USD
Merck Unveils $5 Billion Accelerated Share Buyback
Merck to Present at the UBS Global Healthcare Conference
Merck KGaA to Reach 2014 Outlook One Year Early, 1Q Profit Up
Pfizer to Spin Off Remaining Zoetis Stake
Merck Consumer Care Launches Health and Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their Families
Research and Markets: Global Vaccine Market Forecast to 2017
Research and Markets: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
Good day, everyone, and welcome to Merck's Fourth Quarter 2012 Earnings Conference Call. Today's call is being recorded.
Fitch Rates Merck & Co.'s Proposed Debt 'A+'
Merck to Present Updated Interim Data from Phase II Trial Evaluating Investigational NS3/4A Protease Inhibitor MK-5172 for Chronic Hepatitis C Virus Genotype 1 Infection at the International Liver Congress™